Biggest changeRESULTS OF OPERATIONS Year Ended March 31, (in thousands) 2023 2022 Total revenue $ 412,752 $ 372,827 Total cost of revenue (1) 278,813 225,792 Gross profit 133,939 147,035 Operating expenses Research and development (1) 44,555 51,812 Sales and marketing (1) 66,034 62,957 General and administrative (1) 47,752 45,256 Restructuring charges 1,605 850 Total operating expenses 159,946 160,875 Loss from operations (26,007) (13,840) Other income (expense), net 1,956 (251) Interest expense (10,560) (11,888) Loss on debt extinguishment, net (1,392) (4,960) Net loss before income taxes (36,003) (30,939) Income tax provision 1,940 1,341 Net loss $ (37,943) $ (32,280) (1) Includes stock-based compensation as follows: 28 Table of Contents Year Ended March 31, (in thousands) 2023 2022 Cost of revenue $ 929 $ 1,112 Research and development 2,997 5,843 Sales and marketing 2,397 2,516 General and administrative 4,427 4,358 Total $ 10,750 $ 13,829 Comparison of the Years Ended March 31, 2023 and 2022 Revenue Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Product revenue $ 266,537 65 % $ 223,761 60 % $ 42,776 19 % Service and subscription revenue 132,510 32 % 133,689 36 % (1,179) (1) % Royalty revenue 13,705 3 % 15,377 4 % (1,672) (11) % Total revenue $ 412,752 100 % $ 372,827 100 % $ 39,925 11 % Product Revenue In fiscal 2023, product revenue increased $42.8 million, or 19%, as compared to fiscal 2022.
Biggest changeTable of Contents RESULTS OF OPERATIONS Year Ended March 31, (in thousands) 2024 2023 2022 Restated Restated Total revenue $ 311,600 $ 422,077 $ 383,432 Total cost of revenue (1) 186,711 278,813 225,792 Gross profit 124,889 143,264 157,640 Operating expenses Sales and marketing (1) 60,893 66,034 62,957 General and administrative (1) 51,547 47,752 45,256 Research and development (1) 38,046 44,555 51,812 Restructuring charges 3,280 1,605 850 Total operating expenses 153,766 159,946 160,875 Loss from operations (28,877) (16,682) (3,235) Other income (expense), net (1,746) 1,956 (251) Interest expense (15,089) (10,560) (11,888) Change in fair value of warrant liability 5,137 10,250 60,030 Loss on debt extinguishment, net — (1,392) (4,960) Net income (loss) before income taxes (40,575) (16,428) 39,696 Income tax provision 711 1,940 1,341 Net income (loss) $ (41,286) $ (18,368) $ 38,355 (1) Includes stock-based compensation as follows: Year Ended March 31, (in thousands) 2024 2023 2022 Cost of revenue $ 774 $ 929 $ 1,112 Research and development 1,091 2,997 5,843 Sales and marketing 669 2,397 2,516 General and administrative 2,187 4,427 4,358 Total $ 4,721 $ 10,750 $ 13,829 Comparison of the Years Ended March 31, 2024 and 2023 (restated) Revenue Year Ended March 31, (in thousands) 2024 % of revenue 2023 % of revenue $ Change % Change Restated Product revenue $ 174,879 56 % $ 274,854 65 % $ (99,975) (36) % Service and subscription revenue 126,590 41 133,518 32 (6,928) (5) % Royalty revenue 10,131 3 13,705 3 (3,574) (26) % Total revenue $ 311,600 100 % $ 422,077 100 % $ (110,477) (26) % Product Revenue Table of Contents In fiscal 2024, product revenue decreased $100.0 million, or 36%, as compared to fiscal 2023.
Net Cash Provided by Financing Activities Net cash provided by financing activities was $41.2 million for the year ended March 31, 2023 due primarily to $66.2 million of net cash received from the Rights Offering of 30 million shares of our common stock offset in part by a $20.0 million prepayment of our term debt and term debt principal amortization payments and amendment fees totaling $3.3 million.
Net cash provided by financing activities was $41.2 million for the year ended March 31, 2023 due primarily to $66.2 million of net cash received from the rights offering of 30 million shares of our common stock offset in part by a $20.0 million prepayment of our term debt and term debt principal amortization payments and amendment fees totaling $3.3 million.
Excluding this non-recurring adjustment, product gross margin has declined approximately 370 basis points for fiscal 2023, as compared to fiscal 2022 primarily due to the continuation of pricing pressure on materials cost and freight, as global supply chain constraints disrupted normal procurement channels. Our product mix was also more heavily weighted to lower margin solutions.
Excluding this non-recurring adjustment, product gross margin declined approximately 370 basis points for fiscal 2023, as compared to fiscal 2022 primarily due to the continuation of pricing pressure on materials cost and freight, as global supply chain constraints disrupted normal procurement channels. Our product mix was also more heavily weighted to lower margin solutions.
Loss on debt extinguishment, net Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Loss on debt extinguishment, net (1,392) — % (4,960) (1) % (3,568) (72) % In fiscal 2023, loss on debt extinguishment, net was related to prepayment of our long-term debt.
Loss on debt extinguishment, net Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Restated Restated Loss on debt extinguishment, net $ (1,392) — % $ (4,960) (1) % $ 3,568 72 % In fiscal 2023, loss on debt extinguishment, net was related to prepayment of our long-term debt.
Income tax provision Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Income tax provision $ 1,940 1 % $ 1,341 — % $ 599 45 % Our income tax provision is primarily influenced by foreign and state income taxes.
Income tax provision Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Restated Restated Income tax provision $ 1,940 1 % $ 1,341 — % 599 45 % Our income tax provision is primarily influenced by foreign and state income taxes.
Accordingly, we have established a full valuation allowance against our U.S. and certain foreign net deferred tax assets. Significant management judgement is required in assessing our ability to realize any future benefit from our net deferred tax assets. We intend to maintain this valuation allowance until sufficient positive evidence exists to support its reversal.
Accordingly, we have established a full valuation allowance against our U.S. and certain foreign net deferred tax assets. Significant management judgment is required in assessing our ability to realize any future benefit from our net deferred tax assets. We intend to maintain this valuation allowance until sufficient positive evidence exists to support its reversal.
Commitments and Contingencies Our contingent liabilities consist primarily of certain financial guarantees, both express and implied, related to product liability and potential infringement of intellectual property. We have little history of costs associated with such indemnification requirements and contingent liabilities associated with product liability may be mitigated by our insurance coverage.
Commitments and Contingencies Table of Contents Our contingent liabilities consist primarily of certain financial guarantees, both express and implied, related to product liability and potential infringement of intellectual property. We have little history of costs associated with such indemnification requirements and contingent liabilities associated with product liability may be mitigated by our insurance coverage.
The primary driver of the increase was demand from our large hyperscale customers, as well as continued strong demand globally for data protection and archive solutions. Outside of the Tape and Hyperscale business, our remaining Secondary and Primary storage systems are also offer as a subscription.
The primary driver of the increase was demand from our large hyperscale customers, as well as continued strong demand globally for data protection and archive solutions. Outside of the Tape and Hyperscale business, our remaining Secondary and Primary storage systems are also offered as a subscription.
See Note 9: Income Taxes , to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K. Inventories Manufacturing Inventories Our manufacturing inventory is recorded at the lower of cost or net realizable value, with cost being determined on a first-in, first-out (“FIFO”) basis. Costs include material, direct labor, and an allocation of overhead.
See Note 10: Income Taxes , to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K. Inventories Manufacturing Inventories Table of Contents Our manufacturing inventory is recorded at the lower of cost or net realizable value, with cost being determined on a first-in, first-out (“FIFO”) basis. Costs include material, direct labor, and an allocation of overhead.
This decrease was due in part to certain long-lived products reaching their end-of-service-life, partially offset by new support bookings and the transition towards subscription-based licensing. Royalty Revenue We receive royalties from third parties that license our LTO® media patents through our membership in the LTO® consortium.
This decrease was due in part to certain long-lived products reaching their end-of-service-life, partially offset by new support bookings and the transition towards subscription-based licensing. Royalty Revenue We receive royalties from third parties that license our linear-tape open media patents through our membership in the linear-tape open consortium.
Revenue Recognition Our revenue is derived from three main sources: (a) products, (b) service and subscription, and (c) royalties. Our performance obligations are satisfied at a point in time or over time as stand ready obligations.
Revenue Recognition Table of Contents Our revenue is derived from three main sources: (a) products, (b) service and subscription, and (c) royalties. Our performance obligations are satisfied at a point in time or over time as stand ready obligations.
Product revenue may be impacted by a variety of price adjustments or other factors, including rebates, returns and stock rotation. We use the expected value method to estimate the net consideration expected to be returned by the customer. We use historical data and current trends to drive our estimates.
We reassess standalone selling price determination periodically. Product revenue may be impacted by a variety of price adjustments or other factors, including rebates, returns and stock rotation. We use the expected value method to estimate the net consideration expected to be returned by the customer. We use historical data and current trends to drive our estimates.
Service and subscription Gross Margin Service and subscription gross margin decreased 250 basis points for fiscal 2023, as compared to fiscal 2022.
Service and subscription Gross Margin Service and subscription gross margin decreased 320 basis points for fiscal 2023, as compared to fiscal 2022.
There are significant judgements used when applying Accounting Standards Codification (“ASC”) Topic 606 to contracts with customers. Most of our contracts contain multiple goods and services designed to meet each customers’ unique storage needs.
There are significant judgments used when applying Accounting Standards Codification (“ASC”) Topic 606 to contracts with customers. Most of our contracts contain multiple goods and services designed to meet each customer's unique storage needs.
Other expense, net Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Other income (expense), net $ 1,956 1 % $ (251) 0 % $ (2,207) (879) % 30 Table of Contents In fiscal 2023, other income (expense), net increased $2.2 million or 879%, compared to fiscal 2022.
Other expense, net Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Restated Restated Other income (expense), net $ 1,956 1 % $ (251) 0 % $ 2,207 879 % In fiscal 2023, other income (expense), net increased $2.2 million or 879%, compared to fiscal 2022.
Operating expenses Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Research and development $ 44,555 11 % $ 51,812 14 % $ (7,257) (14) % Sales and marketing 66,034 16 % 62,957 17 % 3,077 5 % General and administrative 47,752 12 % 45,256 12 % 2,496 6 % Restructuring charges 1,605 — % 850 — % 755 89 % Total operating expenses $ 159,946 39 % $ 160,875 43 % $ (929) (1) % In fiscal 2023, research and development expense decreased $7.3 million, or 14%, as compared with fiscal 2022.
Table of Contents Operating expenses Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Restated Restated Sales and marketing $ 66,034 16 % $ 62,957 16 % $ 3,077 5 % General and administrative 47,752 11 % 45,256 12 % 2,496 6 % Research and development 44,555 11 % 51,812 14 % (7,257) (14) % Restructuring charges 1,605 — % 850 — % 755 89 % Total operating expenses $ 159,946 38 % $ 160,875 42 % $ (929) (1) % In fiscal 2023, sales and marketing expenses increased $3.1 million, or 5%, as compared with fiscal 2022.
We anticipate the product revenue portion of our Primary and Secondary storage systems to decrease as we continue to transition to subscription-based offerings. The Devices and media also decreased partially driven by lower volume of LTO® media sales. Service and Subscription Revenue Service and subscription revenue decreased $1.2 million, or 1%, in fiscal 2023 compared to fiscal 2022.
We anticipate the product revenue portion of our Primary and Secondary storage systems to decrease as we continue to transition to subscription-based offerings. The devices and media also decreased partially driven by lower volume of linear-tape open media sales. Service and Subscription Revenue Service and subscription revenue decreased $3.7 million, or 3%, in fiscal 2023 compared to fiscal 2022.
This increase was driven primarily by transition costs as we complete large projects in our IT and facilities infrastructure. In fiscal 2023, restructuring expenses increased $0.8 million, or 89%, as compared with fiscal 2022. This increase is driven by corporate restructuring activities as we consolidated our physical footprint and operations in certain markets.
In fiscal 2023, restructuring expenses increased $0.8 million, or 89%, as compared with fiscal 2022. This increase is driven by corporate restructuring activities as we consolidated our physical footprint and operations in certain markets.
Term loan debt matures on August 5, 2026. (2) Represents aggregate future minimum lease payments under non-cancelable operating leases. (3) Includes primarily non-cancelable inventory purchase commitments. 33 Table of Contents Off-Balance Sheet Arrangements We do not currently have any other off-balance sheet arrangements and do not have any holdings in variable interest entities.
(2) Represents aggregate future minimum lease payments under non-cancelable operating leases. (3) Includes primarily non-cancelable inventory purchase commitments. Off-Balance Sheet Arrangements We do not currently have any other off-balance sheet arrangements and do not have any holdings in variable interest entities.
As a result, during the measurement period, which may be up to one year from the acquisition date, we may record adjustments 35 Table of Contents to the estimated fair value of the assets acquired and liabilities assumed, with the corresponding offset to goodwill.
As a result, during the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the estimated fair value of the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded to the consolidated statements of operations.
We require significant cash resources to meet obligations to pay principal and interest on our outstanding debt, provide for our research and development activities, fund our working capital needs, and make capital expenditures.
We require significant cash resources to meet obligations to pay principal and interest on our outstanding debt, provide for our research and development activities, fund our working capital needs, and make capital expenditures. Our future liquidity requirements will depend on multiple factors, including our research and development plans and capital asset needs.
This decrease was due primarily to a $9.8 million inventory provision recorded during fiscal 2023. Due to longer purchasing lead times and other factors caused by the global supply chain disruptions occurring since the beginning of the COVID-19 pandemic, certain inventory has become obsolete due to next generation products being released and legacy products being discontinued.
Due to longer purchasing lead times and other factors caused by the global supply chain disruptions occurring since the beginning of the COVID-19 pandemic, certain inventory has become obsolete due to next generation products being released and legacy products being discontinued.
Where standalone selling price may not be directly observable (e.g., the performance obligation is not sold separately), we maximize the use of observable inputs by using information including reviewing discounting practices, performance obligations with similar customers and product groupings.
Where standalone selling price may not be directly observable (e.g., the performance obligation is not sold separately), we maximize the use of observable inputs by using information including internal discounting practices, competitor pricing, competitor margins, performance obligations with similar customers and product groupings. Determining the observable inputs and applying them to our performance obligations requires significant judgment.
We generated negative cash flows from operations of approximately $4.9 million and $33.7 million for the fiscal years ended March 31, 2023 and 2022, respectively, and generated net losses of approximately $37.9 million and $32.3 million for the fiscal years ended March 31, 2023 and 2022, respectively.
We generated negative cash flows from operations of approximately $10.2 million and $4.9 million for the fiscal years ended March 31, 2024 and 2023, respectively, and generated net losses of approximately $41.3 million and $18.4 million for the fiscal years ended March 31, 2024 and 2023, respectively.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis compares the change in the consolidated financial statements for fiscal years 2023 and 2022 and should be read together with our consolidated financial statements, the accompanying notes, and other information included in this Annual Report.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion gives effects to the restatement of our consolidated financial statements for the fiscal years ended March 31, 2023 and 2022, discussed in Note 14 to the consolidated financial statements of this Annual Report. and should be read together with our consolidated financial statements, the accompanying notes, and other information included in this Annual Report.
Interest expense Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Interest expense (10,560) (3) % (11,888) (3) % (1,328) (11) % In fiscal 2023, interest expense decreased $1.3 million, or 11%, as compared to fiscal 2022. This decrease was primarily due to a lower principal balance on our Term Loan.
Interest expense Year Ended March 31, (in thousands) 2023 % of revenue 2022 % of revenue $ Change % Change Restated Restated Interest expense $ 10,560 3 % $ 11,888 3 % $ (1,328) (11) % In fiscal 2023, interest expense decreased $1.3 million, or 11%, as compared to fiscal 2022.
Net cash used in operating activities was $33.7 million for the year ended March 31, 2022, primarily attributable to $30.5 million of changes in assets and liabilities due primarily to working capital requirements due to higher manufacturing and service inventories. 32 Table of Contents Net Cash Used in Investing Activities Net cash used in investing activities was $15.6 million for the year ended March 31, 2023, primarily attributable to $12.6 million of capital expenditures and $3.0 million of cash paid related to the deferred purchase price for a prior business acquisition.
Net cash used in investing activities was $15.6 million for the year ended March 31, 2023, primarily attributable to $12.6 million of capital expenditures and $3.0 million of cash paid related to the deferred purchase price for a prior business acquisition.
In particular, the risk factors contained in Item 1A may reflect trends, demands, commitments, events, or uncertainties that could materially impact our results of operations and liquidity and capital resources.
In particular, the risk factors contained in Item 1A may reflect trends, demands, commitments, events, or uncertainties that could materially impact our results of operations and liquidity and capital resources. Our fiscal year ends on March 31 of each calendar year. "Fiscal 2024" in this Annual Report refers to the fiscal year ended March 31, 2024.
We initially measure a returned asset at the carrying amount of the inventory, less any expected costs to recover the goods including potential decreases in value of the returned goods. 34 Table of Contents Income Taxes Deferred tax assets and liabilities are recognized based on temporary differences between the financial reporting and tax bases of assets and liabilities, measured at the enacted tax rates expected to apply to taxable income in the years in which those tax assets or liabilities are expected to be realized or settled.
Income Taxes Deferred tax assets and liabilities are recognized based on temporary differences between the financial reporting and tax bases of assets and liabilities, measured at the enacted tax rates expected to apply to taxable income in the years in which those tax assets or liabilities are expected to be realized or settled.
Year Ended March 31, ( in thousands) 2023 2022 Cash provided by (used in): Operating activities (4,894) (33,728) Investing activities (15,601) (14,124) Financing activities 41,165 20,157 Effect of exchange rate changes 12 51 Net change in cash, cash equivalents, and restricted cash $ 20,682 $ (27,644) Net Cash Used in Operating Activities Net cash used in operating activities was $4.9 million for the year ended March 31, 2023, primarily attributable to cash provided by operating activities excluding changes in assets and liabilities of $1.5 million offset by cash used associated with working capital changes of $6.4 million including cash used related to manufacturing and service inventories of $5.3 million.
Net cash used in operating activities was $4.9 million for the year ended March 31, 2023, primarily attributable to cash provided by operating activities excluding changes in assets and liabilities of $1.5 million offset by cash used associated with working capital changes of $6.4 million including cash used related to manufacturing and service inventories of $5.3 million.
Our total outstanding Term Loan debt was $74.7 million, and we had $20.0 million available to borrow under the PNC Credit Facility as of March 31, 2023.
We had cash and cash equivalents of $25.7 million as of March 31, 2024, which excludes $0.2 million of short-term restricted cash. Our total outstanding Term Loan debt was $87.9 million, and we had $27.3 million available to borrow under the PNC Credit Facility as of March 31, 2024.
This decrease was the result of one-time acquisition-related costs that occurred in the prior year, as well as the overall consolidation of those acquisitions. In fiscal 2023, sales and marketing expenses increased $3.1 million, or 5%, as compared with fiscal 2022.
This increase was driven primarily by transition costs as we complete large projects in our IT and facilities infrastructure. In fiscal 2023, research and development expense decreased $7.3 million, or 14%, as compared with fiscal 2022. This decrease was the result of one-time acquisition-related costs that occurred in the prior year, as well as the overall consolidation of those acquisitions.
Net cash provided by financing activities was $20.2 million for the year ended March 31, 2022, primarily related to borrowings under our credit facility, and proceeds from the new Term Loan offset by the repayment in full of the Senior Secured Term Loan.
Net Cash Provided by Financing Activities Net cash provided by financing activities was $15.7 million for the year ended March 31, 2024 due primarily to borrowings under our Term Loan credit facility.
Upon the conclusion of the measurement period, any subsequent adjustments are recorded to the consolidated statements of operations. Recently Issued and Adopted Accounting Pronouncements For recently issued and adopted accounting pronouncements, see Note 1: Description of Business and Significant Accounting Policies , to our consolidated financial statements.
This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statement of operations. Recently Issued and Adopted Accounting Pronouncements Table of Contents For recently issued and adopted accounting pronouncements, see Note 1: Description of Business and Significant Accounting Policies , to our consolidated financial statements.
Below is a table that shows our contractual obligations as of March 31, 2023 (in thousands): Payments Due by Period (in thousands) Total 1 year or less 1 – 3 Years 3 –5 Years More than 5 years Debt obligations (1) $ 140,407 $ 15,109 $ 108,548 $ 16,750 $ — Future lease commitments (2) 22,993 2,700 3,989 3,042 13,262 Purchase obligations (3) 28,688 28,688 — — — Total $ 192,088 $ 46,497 $ 112,537 $ 19,792 $ 13,262 (1) Consists of (i) principal and interest payments on our term loan based on the amount outstanding and interest rates in effect at March 31, 2023, and (ii) principal, interest, and unused commitment fees on our PNC Credit Facility based on the amount outstanding and rates in effect at March 31, 2023.
Below is a table that shows our contractual obligations as of March 31, 2024 (in thousands): Payments Due by Period (in thousands) Total 1 year or less 1 – 3 Years 3 –5 Years More than 5 years Debt obligations (1) $ 114,546 $ 114,546 $ — $ — $ — Future lease commitments (2) 21,127 2,538 3,776 2,730 12,083 Purchase obligations (3) 32,400 32,400 — — — Total $ 168,073 $ 149,484 $ 3,776 $ 2,730 $ 12,083 (1) Consists of principal on our Term Loan and PNC Credit Facility.
We record a reduction to revenue to account for these items that may result in variable consideration.
We record a reduction to revenue to account for these items that may result in variable consideration. We initially measure a returned asset at the carrying amount of the inventory, less any expected costs to recover the goods including potential decreases in value of the returned goods.
Net cash used in investing activities was $14.1 million for the year ended March 31, 2022, primarily attributable to $7.8 million of business acquisitions and $6.3 million of capital expenditures.
Net Cash Used in Investing Activities Net cash used in investing activities was $5.9 million for the year ended March 31, 2024, primarily attributable to the implementation costs of a new Enterprise Resource Planning system.
We have funded operations through the sale of common stock, term debt borrowings and revolving credit facility borrowings described in Note 5: Debt . On June 1, 2023, the Company entered into amendments to the Term Loan and the PNC Credit Facility.
We have funded operations through the sale of common stock, term debt borrowings and revolving credit facility borrowings described in Note 5: Debt . We are subject to various debt covenants under our debt agreements. Our failure to comply with our debt covenants could materially and adversely affect our financial condition and ability to service our obligations.
If required, there is no assurance that we would be able to obtain sufficient additional funds when needed or that such funds, if available, would be obtainable on terms satisfactory to us.
As such, there can be no assurance that we will be able to obtain additional liquidity when needed or under acceptable terms, if at all. See "Risks Related to our Indebtedness" section of Item 1A. Risk Factors.